Literature DB >> 15193448

A t(1;9)(q23.3 approximately q25;q34) affecting the ABL1 gene in a biphenotypic leukemia.

Juan Ramón González García1, Stefan K Bohlander, Melva Gutiérrez Angulo, María Amparo Esparza Flores, Verónica Judith Picos Cárdenas, Juan Pablo Meza Espinoza, María de la Luz Ayala Madrigal, Horacio Rivera.   

Abstract

Recurring chromosome translocations, which are found in leukemia, can result in the inappropriate expression of oncogenes or in the formation of chimeric genes that code for structurally and functionally abnormal proteins. The chromosomal t(1;9)(q23.3 approximately q25;q34) was found in a patient with biphenotypic leukemia. Fluorescence in situ hybridization (FISH) analysis revealed that the break on chromosome 9 occurred in the ABL1 gene. The breakpoint on chromosome 1 occurred distal to the PBX1 gene at 1q23.3, as shown by FISH using BAC RP11-503N16 and RP11-403P14, which flank the PBX1 locus; hence, the ABL1 gene can be fused with another gene distal to PBX1 gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193448     DOI: 10.1016/j.cancergencyto.2003.10.014

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.

Authors:  Koiti Inokuchi; Satoshi Wakita; Tsuneaki Hirakawa; Hayato Tamai; Norio Yokose; Hiroki Yamaguchi; Kazuo Dan
Journal:  Int J Hematol       Date:  2011-08-24       Impact factor: 2.490

2.  Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.

Authors:  Thomas Perwein; Sabine Strehl; Margit König; Herwig Lackner; Renate Panzer-Grümayer; Georg Mann; Andishe Attarbaschi; Ernst-Christian Urban; Oskar A Haas
Journal:  Haematologica       Date:  2016-04-28       Impact factor: 9.941

3.  Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.

Authors:  Véronique Voisin; Corinne Barat; Trang Hoang; Eric Rassart
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.